Daphne Lainson is a principal in Smart & Biggar's Ottawa office and is the national Chair of the firm's Life Science practice. For almost two decades she has specialized in securing patent protection for chemical, pharmaceutical, and biotechnology related inventions. Daphne advises clients on pharmaceutical regulatory law and provides strategic advice during patent prosecution and following patent grant for pharmaceuticals and biologics. She advises pharmaceutical and biopharmaceutical companies in matters relating to regulatory data exclusivity under the Food and Drug Regulations, supplementary protection under the Certificate of Supplementary Protection Regulations, patent listing under the Patented Medicines (Notice of Compliance) Regulations, and market access issues, including the pricing of patented medicines under the Patented Medicines Regulations. She is listed annually in The Best Lawyers in Canada and Managing Intellectual Property’s IP Stars Handbook: Patents, and was awarded Ottawa Business Woman of the Year 2011 by the Women's Business Network of Ottawa. Daphne is an AIPLA Fellow and Chair of the AIPLA Food and Drug Law Committee. BSc Hons (Chemistry); MSc (Chemistry); LLB. Registered Patent and Trademark Agent. Called to the Ontario Bar in 2001.